Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-96-001609
Filing Date
1996-04-01
Accepted
1996-04-01 00:00:00
Documents
8
Period of Report
1995-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 GENZYME CORPORATION 10-K 632734
2 NOTICE DATED FEBRUARY 22, 1996 EX-10.17 2723
3 CONVERTIBLE DEBT AND DEVELOPMENT FUNDING AGREEMENT EX-10.39 37306
4 COMPUTATION OF WEIGHTED AVERAGE SHARES EX-11 4756
5 SUBSIDIARIES OF THE REGISTRANT EX-21 1862
6 CONSENT OF COOPERS & LYBRAND LLP EX-23.1 1478
7 FINANCIAL DATA SCHEDULE OF GENZYME GENERAL DIV. EX-27.1 2529
8 FINANCIAL DATA SCHEDULE GENZYME TISSUE REPAIR EX-27.2 2458
  Complete submission text file 0000950135-96-001609.txt   688084
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

EIN.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14680 | Film No.: 96543220
SIC: 2834 Pharmaceutical Preparations